Decoding the FDA’s AMT program through process analytical technology
Learn how process analytical technology enables advanced manufacturing technologies under the FDA AMT program and transforms pharma production. Explore the insights today.
SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Learn how process analytical technology enables advanced manufacturing technologies under the FDA AMT program and transforms pharma production. Explore the insights today.